Search

Arbutus Biopharma Corp

Uždarymo kaina

5 0.2

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.99

Max

5.04

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-175M

-5.1M

Pardavimai

-178M

1M

P/E

Sektoriaus vid.

6.494

56.432

Pelnas, tenkantis vienai akcijai

-0.03

Pelno marža

-507.199

Darbuotojai

19

EBITDA

-175M

-5.1M

Dividendai

By Acuity

Kitas uždarbis

2026-11-12

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

110M

1B

Ankstesnė atidarymo kaina

4.8

Ankstesnė uždarymo kaina

5

Arbutus Biopharma Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-21 23:56; UTC

Revvity Inc is trading modestly higher in after-market hours, positioned above its 20-day moving average and near the upper end of its one-month range.

2026-09-21 23:56; UTC

Correlated Moves

Eversource Energy is advancing in after-market hours, influenced by OGE Energy's gains earlier in the session, though it remains below its 20-day moving average.

2026-09-21 23:56; UTC

Owens Corning is trading modestly higher in after-market hours, recovering from a recent trend of six consecutive sessions ending lower.

2026-09-21 23:56; UTC

Ameriprise Financial Inc is trading slightly higher in after-market hours, recovering from an earlier dip but remains below its 20-day moving average.

2026-09-21 23:56; UTC

Pool Corp is trading modestly higher in after-market hours following a decline in the Chicago Fed National Activity Index for August, reflecting slower economic growth.

2026-09-21 23:55; UTC

Chimera Investment Corp is trading roughly flat in after-market hours, about 2.48% below its 20-day moving average.

2026-09-21 23:55; UTC

Lamb Weston Holdings Inc is trading modestly lower in after-market hours, continuing the earlier session's weakness and remaining below its 20-day moving average.

2026-09-21 23:55; UTC

Ziff Davis Inc declined during after-market hours on Monday, influenced by broader economic slowdown signals, despite remaining above its 20-day moving average.

2026-09-21 23:55; UTC

Old Republic International Corp is trading modestly higher in after-market hours, recovering slightly after a series of declines over the previous five sessions.

2026-09-21 23:55; UTC

Carlyle Group Inc is trading modestly lower in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

2026-09-21 23:55; UTC

Mitek Systems Inc is up in after-market trading, reaching a peak despite remaining below its 20-day moving average amid slowing economic growth signals.

2026-09-21 23:55; UTC

Truist Financial Corp is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

2026-09-21 23:55; UTC

Darling Ingredients Inc's stock is trading modestly higher in after-market hours, despite a decline in the Chicago Fed National Activity Index for August.

2026-09-21 23:55; UTC

Solaredge Technologies Inc is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

2026-09-21 23:55; UTC

Booking Holdings Inc. is trading modestly higher in after-market hours following Monday's close, despite remaining significantly below its 20-day moving average.

2026-09-21 23:55; UTC

OraSure Technologies Inc. is trading modestly higher in after-market hours, marking its eighth consecutive session of gains while remaining above its 20-day moving average.

2026-09-21 23:55; UTC

Revolve Group Inc. is trading roughly flat in after-market hours, fluctuating within a range amid economic growth concerns from the Chicago Fed National Activity Index.

2026-09-21 23:52; UTC

News

Boeing Co. has secured two defense contracts worth $41.5 million, while shares have declined slightly in after-market trading, remaining near the lower end of their one-month range.

2026-09-21 23:52; UTC

Yelp Inc. is declining in after-market trading, remaining significantly below its 20-day moving average and continuing a trend of lower daily closes.

2026-09-21 23:51; UTC

Cathay General Bancorp is trading modestly higher in after-market hours, recovering from a slight dip and reaching a peak cumulative return of nearly 1%.

2026-09-21 23:51; UTC

Janus International Group Inc has advanced modestly in after-market trading, continuing a pattern of strength observed throughout the session.

2026-09-21 23:51; UTC

CoStar Group Inc rebounded in after-market trading, showing a cumulative return above its prior close despite remaining below its 20-day moving average.

2026-09-21 23:51; UTC

Cooper Companies Inc is trading modestly higher during after-market hours, despite a significant decline over the past month and trading below its 20-day moving average.

2026-09-21 23:51; UTC

Social Media

Rocket Lab Corp's stock rises in after-market trading following Cantor Fitzgerald's bullish note, reiterating a $122 price target amid successful launches and an upcoming acquisition.

2026-09-21 23:51; UTC

Cabaletta Bio Inc saw notable gains in after-market trading, recovering from a low return shortly after the market closed to a higher return by late session.

2026-09-21 23:51; UTC

Molson Coors Beverage Co sees a modest increase in after-market trading, reaching its highest cumulative return since Monday's close, despite being below its 20-day moving average.

2026-09-21 23:51; UTC

Allstate Corp is seeing notable upward movement in after-market trading, recovering from six consecutive sessions of lower finishes.

2026-09-21 23:51; UTC

CRISPR Therapeutics AG is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

2026-09-21 23:51; UTC

OGE Energy Corp is trading modestly higher in after-market hours, following notable upward movement from its previous close, despite remaining below its 20-day moving average.

2026-09-21 23:51; UTC

United Therapeutics Corp is trading modestly higher in after-market hours, recovering from an initial dip and showing volatility since Monday's close.

Akcijų palyginimas

Kainos pokytis

Arbutus Biopharma Corp Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Arbutus Biopharma Corp

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of imdusiran (AB-729), a proprietary subcutaneously-delivered RNAi therapeutic product candidate that suppresses all HBV antigens, including HBsAg expression. The company's research and development programs include AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune system; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has licensing agreements with Gritstone Oncology, Inc; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Barinthus Biotherapeutics plc to evaluate VTP-300. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.